Recent News

• 04.24.2025 - Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton
• 04.15.2025 - Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
• 03.13.2025 - FDA Issues Clearance for ReWalk 7 Exoskeleton
• 03.07.2025 - Q4 2024 Lifeward, Inc. Earnings Conference Call
• 03.06.2025 - Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
• 03.05.2025 - Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
• 02.20.2025 - Lifeward Investor Event
• 02.19.2025 - Lifeward Announces CEO Transition

Recent Filings

• 04.15.2025 - EX-99.1 EX-99.1
• 04.15.2025 - 8-K Current report
• 04.14.2025 - 8-K Current report
• 03.07.2025 - 8-K Current report
• 03.07.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.07.2025 - 8-K Current report
• 03.07.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.07.2025 - EX-99.1 EX-99.1
• 02.20.2025 - 8-K Current report
• 02.14.2025 - CORRESP Correspondence